A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease
Status:
Recruiting
Trial end date:
2024-06-13
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability and effect of study drug
LY3372689 in participants with early symptomatic Alzheimer's Disease